Mild hyperhomocysteinemia, C677T polymorphism on methylenetetrahydrofolate reductase gene and the risk of macroangiopathy in type 2 diabetes: A prospective study

Acta Diabetologica

Volumn 48, Issue 2, 2011, Pages 95-101

  Russo, Giuseppina Tiziana ^a   Di Benedetto, Antonino ^a   Magazzù, Domenico ^b   Giandalia, Annalisa ^a   Giorda, Carlo Bruno ^c   Ientile, Riccardo ^d   Previti, Marcello ^a   Di Cesare, Enrico ^a   Cucinotta, Domenico ^a  

^a UNIVERSITY OF MESSINA   (Italy)

^b UNIVERSITY OF PAVIA   (Italy)

^c Metabolism and Diabetes Unit   (Italy)

^d UNIVERSITY OF MESSINA   (Italy)

Author keywords

Diabetes; Homocysteine; Macroangiopathy; MTHFR; Polymorphism

Indexed keywords

CREATININE; CYANOCOBALAMIN; FOLIC ACID; HOMOCYSTEINE;

ADULT; AMINO ACID BLOOD LEVEL; ARTICLE; CARDIOVASCULAR DISEASE; CREATININE CLEARANCE; CYANOCOBALAMIN BLOOD LEVEL; DIABETIC ANGIOPATHY; FEMALE; FOLIC ACID BLOOD LEVEL; GENE; GENETIC POLYMORPHISM; GENETIC RISK; GENOTYPE; HOMOCYSTEINE BLOOD LEVEL; HUMAN; HYPERHOMOCYSTEINEMIA; MAJOR CLINICAL STUDY; MALE; METHYLENETETRAHYDROFOLATE REDUCTASE GENE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK FACTOR; SEX RATIO; VITAMIN BLOOD LEVEL;

AGED; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; HYPERHOMOCYSTEINEMIA; MALE; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; PREVALENCE; PROSPECTIVE STUDIES; RISK FACTORS; SEVERITY OF ILLNESS INDEX;

EID: 79960260266     PISSN: 09405429     EISSN: 14325233     Source Type: Journal    
DOI: 10.1007/s00592-009-0169-5     Document Type: Article

References (34)

1. EK Hoogeveen PJ Kostense PJ Beks AJ Mackaay C Jakobs LM Bouter, et al. 1998 Hyperhomocysteinemia is associated with an increased risk of cardiovascular disease, especially in non-insulin-dependent diabetes mellitus: a population-based study Arterioscler Thromb Vasc Biol 18 133 138 9445267 1:STN:280:DyaK1c7gs1Sntw%3D%3D (Pubitemid 28047610)
2. AN Elias S Eng 2005 Homocysteine concentrations in patients with diabetes mellitus-relationship to microvascular and macrovascular disease Diabetes Obes Metab 7 117 121 15715884 10.1111/j.1463-1326.2004.00376.x 1:CAS:528: DC%2BD2MXjtVGlt7s%3D (Pubitemid 40352726)
3. MC Audelin J Genest Jr 2001 Homocysteine and cardiovascular disease in diabetes mellitus Atherosclerosis 159 497 511 11730832 10.1016/S0021-9150(01) 00531-7 1:CAS:528:DC%2BD3MXos1Cnu74%3D (Pubitemid 33127265)
4. PF Jacques AG Bostom PW Wilson S Rich IH Rosenberg J Selhub 2001 Determinants of plasma total homocysteine concentration in the Frammingham Offspring Cohort Am J Clin Nutr 73 613 621 11237940 1:CAS:528: DC%2BD3MXhs1SgsLw%3D (Pubitemid 32176514)
5. P Frosst HJ Blom R Milos P Goyette CA Sheppard RG Matthews, et al. 1995 A candidate genetic risk factor for vascular disease: a common mutation at the methylenetetrahydrofolate reductase Nat Genet 10 111 113 7647779 10.1038/ng0595-111 1:CAS:528:DyaK2MXlsVymt78%3D
6. M Klerk P Verhoef R Clarke HJ Blom FJ Kok EG Schouten The MTHFR Studies Collaboration Group 2002 MTHFR 677 CT polymorphism and risk of coronary heart disease JAMA 288 2023 2031 12387655 10.1001/jama.288.16.2023 1:CAS:528:DC%2BD3sXpsFOqsrw%3D (Pubitemid 35204693)
7. GT Russo A Di Benedetto C Giorda E Alessi G Crisafulli R Ientile, et al. 2004 Correlates of total homocysteine plasma concentration in type 2 diabetes Eur J Clin Invest 34 197 204 15025678 10.1111/j.1365-2362.2004.01319.x 1:CAS:528:DC%2BD2cXjs1SrtLw%3D (Pubitemid 38406634)
8. A Passaro F Calzoni S Volpato ED Nora PL Pareschi PF Zamboni, et al. 2003 Effect of metabolic control on homocysteine levels in type 2 diabetic patients: a 3-year follow-up J Intern Med 254 264 271 12930236 10.1046/j.1365-2796.2003. 01184.x 1:CAS:528:DC%2BD3sXnvFejtrs%3D (Pubitemid 37070228)
9. EK Hoogeven PJ Kostense C Jakobs 1997 Does metformin increase the serum total homocysteine level in NIDDM? J Int Med 242 389 394 10.1046/j.1365-2796. 1997.00231.x
10. M Buysschaert AS Dramais PE Wallemacq MP Hermans 2000 Hyperhomocysteinemia in type 2 diabetes: relationship to macroangiopathy, nephropathy, and insulin resistance Diabetes Care 23 1816 1822 11128359 10.2337/diacare.23.12.1816 1:STN:280:DC%2BD3M7hsVaisg%3D%3D
11. The Expert Committee on the Diagnosis of Diabetes Mellitus 1997 Report of the expert committee on the diagnosis and classification of diabetes mellitus Diabetes Care 20 1183 1197
12. CB Giorda A Avogaro M Maggini F Lombardo E Mannucci S Turco Diabetes and Informatics Study Group 2008 Recurrence of cardiovascular events in patients with type 2 diabetes: epidemiology and risk factors Diabetes Care 31 2154 2159 18782902 10.2337/dc08-1013
13. The DAI Study Group 2004 Prevalence of coronary heart disease in a cohort of type 2 diabetic patients in Italy: the DAI study Diabet Med 21 738 745 10.1111/j.1464-5491.2004.01230.x (Pubitemid 38916219)
14. GA Rose H Blackburn 1968 Cardiovascular survey methods Monogr Ser World Health Organ 56 1 188 4972212 1:STN:280:DyaF1M%2Fjt1Ggtg%3D%3D
15. GN Welch J Loscalzo 1998 Homocysteine and atherothrombosis N Engl J Med 338 1042 1050 9535670 10.1056/NEJM199804093381507 1:CAS:528:DyaK1cXislaqtr4%3D (Pubitemid 28180407)
16. PM Ueland H Refsum SA Beresford SE Vollset 2000 The controversy over homocysteine and cardiovascular risk Am J Clin Nutr 72 324 332 10919921 1:CAS:528:DC%2BD3cXlsFyhsbc%3D (Pubitemid 30623491)
17. A Araki Y Sako H Ito 1993 Plasma homocysteine concentrations in Japanese patients with non insulin-dependent diabetes mellitus: effect of parenteral methylcobalamin treatment Atherosclerosis 103 149 157 8292092 10.1016/0021-9150(93)90258-V 1:STN:280:DyaK2c7itFOisQ%3D%3D (Pubitemid 23360929)
18. A Chico A Perez A Cordoba R Arcelus G Carreras A De Leiva, et al. 1998 Plasma homocysteine is related to albumin excretion rate in patients with diabetes mellitus: a new link between diabetic nephropathy and cardiovascular disease? Diabetologia 41 684 693 9662051 10.1007/s001250050969 1:CAS:528:DyaK1cXjs1Ggsrc%3D (Pubitemid 28261404)
19. EK Hoogeveen PJ Kostense C Jakobs JM Dekker G Nijpels RJ Heine, et al. 2000 Hyperhomocysteinemia increases risk of death, especially in type 2 diabetes: 5-year follow-up of the Hoorn study Circulation 101 1506 1511 10747342 1:CAS:528:DC%2BD3cXivVyhsbs%3D (Pubitemid 30180885)
20. M Soinio J Marniemi M Laakso S Lehto T Ronnemaa 2004 Elevated plasma homocysteine level is an independent predictor of coronary heart disease events in patients with type 2 diabetes mellitus Ann Intern Med 140 94 100 14734331
21. G Ndrepepa A Kastrati S Braun W Koch K Kölling J Mehilli, et al. 2006 A prospective cohort study of predictive value of homocysteine in patients with type 2 diabetes and coronary artery disease Clin Chim Acta 373 70 76 16814762 10.1016/j.cca.2006.05.011 1:CAS:528:DC%2BD28XptFSqsLw%3D (Pubitemid 44308543)
22. J Selhub 2006 The many facets of hyperhomocysteinemia: studies from the Framingham cohorts J Nutr 136 1726S 1730S 16702347 1:CAS:528: DC%2BD28Xlt1Wmsrs%3D (Pubitemid 43765388)
23. L Brattström DEL Wilcken 2000 Homocysteine and cardiovascular disease: cause or effect? Am J Clin Nutr 72 315 323 10919920 (Pubitemid 30620632)
24. A Passaro K D'Elia P Pareschi F Calzoni M Carantoni R Fellin, et al. 2000 Factors influencing plasma homocysteine levels in type 2 diabetes Diabetes Care 23 420 421 10868878 10.2337/diacare.23.3.420 1:STN:280:DC%2BD3cvntFygsA%3D%3D (Pubitemid 30131757)
25. GT Russo S Friso PF Jacques G Rogers D Cucinotta PW Wilson, et al. 2003 Age and gender affect the relation between methylenetetrahydrofolate reductase C677T genotype and fasting plasma homocysteine concentrations in the Framingham Offspring Study cohort J Nutr 133 3416 3421 14608052 1:CAS:528: DC%2BD3sXovFKgsr8%3D (Pubitemid 37409467)
26. K Arai Y Yamasaki YY Kaijmoto H Watada Y Umayahara M Kodama, et al. 1997 Association of methylenetetrahydrofolate reductase gene polymorphism with carotid arterial wall thickening and myocardial infarction risk in NIDDM Diabetes 46 2102 2104 9392503 1:CAS:528:DyaK2sXnslGqtb0%3D (Pubitemid 27512103)
27. G Hasegawa H Obayashi K Kamiuchi M Nakai T Kanatsuna M Yamaguchi, et al. 2003 The association between end-stage diabetic nephropathy and methylenetetrahydrofolate reductase genotype with macroangiopathy in type2 diabetes mellitus Exp Clin Endocrinol Diabetes 111 132 138 12784186 10.1055/s-2003-39785 1:CAS:528:DC%2BD3sXks1GrsLw%3D (Pubitemid 36682051)
28. J Sun Y Xu J Xue Y Zhu H Lu 2005 Methylenetetrahydrofolate reductase polymorphism associated with susceptibility to coronary heart disease in Chinese type 2 diabetic patients Mol Cell Endocrinol 229 95 101 15607533 10.1016/j.mce.2004.09.003 1:CAS:528:DC%2BD2cXhtVyqs7jJ (Pubitemid 40018087)
29. A Mazza C Motti A Nulli A Pastore F Andreotti V Ammaturo, et al. 1999 Serum homocysteine, MTHFR gene polymorphism, and carotid intimal-medial thickness in NIDDM subjects J Thromb Thrombolysis 8 207 212 10500310 10.1023/A:1008962220476 1:CAS:528:DyaK1MXnvVGlsrw%3D (Pubitemid 29497774)
30. L Scaglione R Gambino E Rolfo E Lillaz M Gai M Cassader, et al. 2002 Plasma homocysteine, methylenetetrahydrofolate reductase gene polymorphism and carotid intima-media thickness in Italian type 2 diabetic patients Eur J Clin Invest 32 24 28 11851723 10.1046/j.1365-2362.2002.00936.x 1:CAS:528: DC%2BD38XhsVGlsLc%3D (Pubitemid 36228379)
31. The Heart Outcomes Prevention Evaluation (HOPE) 2 Investigators 2006 Homocysteine lowering with folic acid and B vitamins in vascular disease N Engl J Med 354 1567 1577 10.1056/NEJMoa060900
32. B-Vitamin Treatment Trialists' Collaboration 2006 Homocysteine-lowering trials for prevention of cardiovascular events: a review of the design and power of the large randomized trials Am Heart J 151 282 287 10.1016/j.ahj.2005.04.025 (Pubitemid 43144727)
33. A Avogaro C Giorda M Maggini E Mannucci R Raschetti R Raschetti R Raschetti R Raschetti F Lombardo Diabetes, Informatics Study Group, Association of Clinical Diabetologists, Istituto Superiore di Sanità 2007 Incidence of coronary heart disease in type 2 diabetic men and women: impact of microvascular complications, treatment, and geographic location Diabetes Care 30 1241 1247 17290034 10.2337/dc06-2558 (Pubitemid 46684654)
34. TY Cheng SF Wen BC Astor XG Tao JM Samet CP Wen 2008 Mortality risks for all causes and cardiovascular diseases and reduced GFR in a middle-aged working population in Taiwan Am J Kidney Dis 52 1051 1060 18706747 10.1053/j.ajkd.2008. 05.030 1:CAS:528:DC%2BD1MXmt1Gmurc%3D